|
Plasmids
|
D010957 |
[Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.
] |
|
Plasminogen
|
D010958 |
[Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent.
] |
|
Tissue Plasminogen Activator
|
D010959 |
[A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases.
] |
|
ethyl 5-cyano-1,6-dihydro-2-methyl-6-oxo-3-pyridinecarboxylate
|
C074330 |
|
|
DAU 6236
|
C074331 |
|
|
CHIR 4531
|
C088973 |
|
|
Plasma Cells
|
D010950 |
[Specialized forms of antibody-producing B-LYMPHOCYTES. They synthesize and secrete immunoglobulin. They are found only in lymphoid organs and at sites of immune responses and normally do not circulate in the blood or lymph. (Rosen et al., Dictionary of Immunology, 1989, p169 & Abbas et al., Cellular and Molecular Immunology, 2d ed, p20)
] |
|
4-(3-(benzotriazol-1-yl)propyl)-1-(2-methoxyphenyl)piperazine
|
C088974 |
|
|
Plasma Exchange
|
D010951 |
[Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions.
] |
|
Vsx2 protein, mouse
|
C088975 |
|
|
Plasma Substitutes
|
D010952 |
[Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration.
] |
|
Cntn3 protein, rat
|
C088976 |
|
|
Plasma Volume
|
D010953 |
[Volume of PLASMA in the circulation. It is usually measured by INDICATOR DILUTION TECHNIQUES.
] |
|
ginnacin protein, Ginkgo biloba
|
C088977 |
|
|
Plasmacytoma
|
D010954 |
[Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites.
] |
|
Ids2 protein, Hordeum vulgare
|
C088978 |
|
|
Plasmalogens
|
D010955 |
[GLYCEROPHOSPHOLIPIDS in which one of the two acyl chains is attached to glycerol with an ether alkenyl linkage instead of an ester as with the other glycerophospholipids.
] |
|
fusB protein, Synechocystis
|
C088979 |
|
|
Plasmapheresis
|
D010956 |
[Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use.
] |
|
9-dihydrotaxol
|
C088970 |
|
